A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MMV / Medicines for Malaria Venture

[Related PubMed/MEDLINE]
Total Number of Papers: 40
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MMV  (>> Co-occurring Abbreviation)
Long Form:   Medicines for Malaria Venture
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Early Antischistosomal Leads Identified from in Vitro and in Vivo Screening of the Medicines for Malaria Venture Pathogen Box. ---
2019 Leveraging the Medicines for Malaria Venture malaria and pathogen boxes to discover chemical inhibitors of East Coast fever. ---
2018 Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box. ELISA, SI
2018 Discovery of Plasmodium (M)TRAP-Aldolase Interaction Stabilizers Interfering with Sporozoite Motility and Invasion. TRAP
2018 Encapsulation of OZ439 into Nanoparticles for Supersaturated Drug Release in Oral Malaria Therapy. FNP, NPs
2018 High-Content Screening of the Medicines for Malaria Venture Pathogen Box for Plasmodium falciparum Digestive Vacuole-Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery. CQ, DV, PCD
2018 Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis. PGI
2018 Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni. ---
2018 Screening of the Pathogen Box for inhibitors with dual efficacy against Giardia lamblia and Cryptosporidium parvum. EC50, Nluc
10  2017 Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates. ---
11  2017 In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum. ---
12  2017 Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates. NTM, TB
13  2017 Screening of the 'Stasis Box' identifies two kinase inhibitors under pharmaceutical development with activity against Haemonchus contortus. ---
14  2017 Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors. ---
15  2017 The Candidate Antimalarial Drug MMV665909 Causes Oxygen-Dependent mRNA Mistranslation and Synergizes with Quinoline-Derived Antimalarials. ROS
16  2016 A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters. FRET
17  2016 Alternatives to currently used antimalarial drugs: in search of a magic bullet. ---
18  2016 Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box Against Intracellular Leishmania major Amastigotes. CL
19  2016 Exploration of Scaffolds from Natural Products with Antiplasmodial Activities, Currently Registered Antimalarial Drugs and Public Malarial Screen Data. CRAD, NAA
20  2016 In Vitro Screening of the Open-Source Medicines for Malaria Venture Malaria Box Reveals Novel Compounds with Profound Activities against Theileria annulata Schizonts. ---
21  2016 In Vivo and In Vitro Optimization of Screening Antimalarial Hits toward Lead Molecules for Preclinical Development. DMPK
22  2016 Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways. MOA, UHPLC-MS
23  2016 Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box. PfTrxR
24  2016 Screening of the 'Pathogen Box' identifies an approved pesticide with major anthelmintic activity against the barber's pole worm. ---
25  2016 Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis. AE
26  2016 [Development and Distribution of Drugs for NTDs: Efforts of One Pharmaceutical Company]. DNDi, HIV, NTDs, PDP, TB
27  2015 An open source business model for malaria. ---
28  2015 Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box. ERM
29  2014 A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs. PfDGFA, PfSMFA
30  2014 Antimalarial drug discovery - the path towards eradication. ---
31  2014 Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box. ---
32  2014 Orally active antischistosomal early leads identified from the open access malaria box. ---
33  2014 Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica. SI
34  2013 MMV in partnership: the Eurartesim experience. ---
35  2012 Back to the future: lessons learned in modern target-based and whole-cell lead optimization of antimalarials. ---
36  2010 Sustainable development of a GCP-compliant clinical trials platform in Africa: the malaria clinical trials alliance perspective. ACRP, AMMREN, GCP, MCTA, MVI
37  2010 The pharmaceutical death-ride of dihydroartemisinin. ---
38  2009 Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children. AL
39  2007 In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models. ---
40  2006 Medicines for Malaria Venture: sustaining antimalarial drug development. ---